Brief: Enorama Plans To Carry Out A Directed Issue Of About SEK 20 Mln
July 17 (Reuters) - Enorama Pharma AB ERMA.ST :
* ENORAMA PHARMA AB PLANS TO CARRY OUT A DIRECTED ISSUE OF
ABOUT
SEK 20 MILLION TO STRATEGICALLY IMPORTANT INVESTOR
* ISSUE PRICE SET AT SEK 1.8 PER SHARE
* TO CARRY OUT A DIRECTED ISSUE OF 11,070,000 SHARES TO
MADHAT AB
Source text for Eikon: ID:nWkr5hPWwt
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO